Daily as of 3 Nov 16:00 ET
- Price
- above both $32.85 vs 50 $29.41 / 200 $21.63
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 16 Sep 2026 · projected 26 bars out
CAI | Caris Life SciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$32.85
+$0.75 (+2.34%)
Caris Life Sciences (CAI) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $34.33 vs 50 $22.47 / 200 $29.82
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 20 Apr 2026 · projected 22 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $32.85 vs 50 $31.04 / 200 $24.00
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Sep 2026 | 🟨Golden steep | daily | 26 bars out | Not tested |
| week of 20 Apr 2026 | 💀Death steep | weekly | 22 bars out | — |
| 7 Jul 2025 | 💀Death | daily | 13 bars out | — |
| week of 1 Mar 2021 | 🟨Golden moderate | weekly | 25 bars out | Not tested |
| 24 Sep 2020 | 🟨Golden | daily | 30 bars out | Not tested |
About CAI
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$123M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid